首页> 外文期刊>International journal of infectious diseases : >ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores
【24h】

ABC2-SPH risk score for in-hospital mortality in COVID-19 patients: development, external validation and comparison with other available scores

机译:Covid-19患者中医院死亡率的ABC2-SPH风险评分:发展,外部验证和与其他可用分数的比较

获取原文
           

摘要

Objectives The majority of available scores to assess mortality risk of coronavirus disease 2019 (COVID-19) patients in the emergency department have high risk of bias. Therefore, this cohort aimed to develop and validate a score at hospital admission for predicting in-hospital mortality in COVID-19 patients and to compare this score with other existing ones. Methods Consecutive patients (≥ 18 years) with confirmed COVID-19 admitted to the participating hospitals were included. Logistic regression analysis was performed to develop a prediction model for in-hospital mortality, based on the 3978 patients admitted between March–July, 2020. The model was validated in the 1054 patients admitted during August–September, as well as in an external cohort of 474 Spanish patients. Results Median (25–75th percentile) age of the model-derivation cohort was 60 (48–72) years, and in-hospital mortality was 20.3%. The validation cohorts had similar age distribution and in-hospital mortality. Seven significant variables were included in the risk score: age, blood urea nitrogen, number of comorbidities, C-reactive protein, SpO 2 /FiO 2 ratio, platelet count, and heart rate. The model had high discriminatory value (AUROC 0.844, 95% CI 0.829–0.859), which was confirmed in the Brazilian (0.859 [95% CI 0.833–0.885]) and Spanish (0.894 [95% CI 0.870–0.919]) validation cohorts, and displayed better discrimination ability than other existing scores. It is implemented in a freely available online risk calculator (https://abc2sph.com/). Conclusions An easy-to-use rapid scoring system based on characteristics of COVID-19 patients commonly available at hospital presentation was designed and validated for early stratification of in-hospital mortality risk of patients with COVID-19.
机译:目标是评估急诊部冠状病毒疾病的死亡率风险的大多数可用评分(Covid-19)患者的偏见风险很高。因此,这一群组旨在开发和验证医院入院录取的分数,以预测Covid-19患者的住院死亡率,并与其他现有的患者进行比较。方法包括涉及参与医院的确认Covid-19的连续患者(≥18岁)。在2020年3月至7月间录取的3978名患者中,进行了逻辑回归分析,以开发用于住院内死亡的预测模型。该模型在8月至9月期间录取的1054名患者以及外部队列中验证474名西班牙患者。结果中位数(25-75百分位数)模型衍生队队的年龄为60(48-72)岁,院内死亡率为20.3%。验证队列具有相似的年龄分布和住院死亡率。风险评分中包含七种显着变量:年龄,血尿尿素氮,合并症数量,C反应蛋白,SPO 2 / FIO 2比例,血小板计数和心率。该模型具有高鉴别值(AuCoC 0.844,95%CI 0.829-0.859),其在巴西人(0.859 [95%[95%CI 0.833-0.885])和西班牙语(0.894 [95%CI 0.870-0.919])验证队列,并显示比其他现有分数更好的歧视能力。它是在可自由的在线风险计算器(https://abc2sph.com/)中实现的。结论设计并验证了基于医院介绍的Covid-19患者特征的易于使用的快速评分系统,并验证了Covid-19患者的早期死亡率风险的早期分层。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号